Dutch ask for EU help on Indian seizures
This article was originally published in Scrip
It seems the Dutch themselves are just as confused on the legality of their actions on the seizures of Indian made generics in transit to developing countries. The Dutch Ministry of Economic Affairs told Scrip it has written a letter to European Commissioner for taxation and customs union, L�szl� Kov�cs, asking him to shed some light on the matter.
You may also be interested in...
The US Food and Drug Administration recently signalled its desire to work more closely with other drug regulators in assessing the quality of pharmaceutical manufacturing facilities around the world.
It seems as if the US FDA is softening its stance on assessing the quality of pharmaceutical manufacturing facilities around the world in future, with an apparent desire to work more closely with other drug regulators. However, incorporating the regulators from countries such as India, China and Japan into a global inspectorate still looks problematical.
Large pharmaceutical companies and Médecins sans Frontières may not often see eye-to-eye over access to medicines in poor countries. But it seems as if industry and the humanitarian body, a prominent critic, do agree that competition works in improving access to vaccines, even though they don't agree about the mechanisms of price setting.